AA
ALPS Advisors Portfolio holdings
AUM
$17.2B
1-Year Est. Return
16.42%
This Fund
S&P 500
1 Year Est. Return
+16.42%
AUM
$17.2B
AUM Growth
-$788M
(-4.4%)
Holding
1,092
Top Buys
| 1 | +$103M | |
| 2 | +$42.8M | |
| 3 | +$40.5M | |
| 4 |
Hess Midstream
HESM
|
+$33.9M |
| 5 |
First Majestic Silver
AG
|
+$33.6M |
Top Sells
| 1 | +$1.35B | |
| 2 | +$86.3M | |
| 3 | +$55.9M | |
| 4 |
Mastercard
MA
|
+$42.6M |
| 5 |
Newmont
NEM
|
+$36M |
Sector Composition
| 1 | Energy | 62.96% |
| 2 | Materials | 5.89% |
| 3 | Technology | 4.09% |
| 4 | Financials | 3.1% |
| 5 | Consumer Discretionary | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Ryman Hospitality Properties
RHP
$6.21B
| – | – |
-3,106
|
|
||
|
RNAM
1077
DELISTED
Avidity Biosciences
RNAM
| – | – |
-70,573
|
|
||
1078
Rhythm Pharmaceuticals
RYTM
$6.1B
| – | – |
-33,000
|
|
||
1079
STAG Industrial
STAG
$7.45B
| – | – |
-8,580
|
|
||
1080
Seagate
STX
$82.3B
| – | – |
-125,131
|
|
||
1081
Stanley Black & Decker
SWK
$12.1B
| – | – |
-316,258
|
|
||
1082
Terns Pharmaceuticals
TERN
$4.57B
| – | – |
-42,630
|
|
||
|
TRML
1083
DELISTED
Tourmaline Bio
TRML
| – | – |
-12,465
|
|
||
1084
Trevi Therapeutics
TRVI
$1.68B
| – | – |
-58,292
|
|
||
1085
Vale
VALE
$65.6B
| – | – |
-52,026
|
|
||
|
VBTX
1086
DELISTED
Veritex Holdings
VBTX
| – | – |
-19,144
|
|
||
1087
Vir Biotechnology
VIR
$1.43B
| – | – |
-66,109
|
|
||
1088
Viridian Therapeutics
VRDN
$2.76B
| – | – |
-39,961
|
|
||
1089
Viatris
VTRS
$16.7B
| – | – |
-2,463,207
|
|
||
|
SMC
1090
Summit Midstream
SMC
$392M
| – | – |
-27,646
|
|
||
|
MAZE
1091
Maze Therapeutics
MAZE
$2.18B
| – | – |
-13,742
|
|
||
|
MTSR
1092
DELISTED
Metsera Inc
MTSR
| – | – |
-49,943
|
|